AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Oper...(conditions where there is an unmet need ...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
Date:6/29/2009
conditions where there is an unmet need for improved safety and efficacy. The company applies its proprietary NanoTab dosage form and delivery technologies to enhance the safety, therapeutic benefit and commercial attractiveness of currently approved compounds. For additional information about AcelRx Pharmaceuticals visit http://www.acelrx.com.
'/>"/>
| SOURCE AcelRx Pharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
2. AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
(Date:11/30/2009)...November 30 Health Robotics today ...ment plans and product specifications,for a new an...eral,Nutrition", a new key component of its i.v. R...gas, ASHP (Booth # 114). , "I look forwar...Nstation,s blueprints and to find out if TPNstatio...
(Date:11/30/2009)... Nov. 30 Decision Resources, one o...focusing on pharmaceutical and healthcare issues, ...n Russia will grow nine percent annually over the ... 2013. This growth will be driven mainly by increa...d use of more-expensive therapies like pegylated i...
(Date:11/30/2009)...30 Intelliject, Inc. today announc...or a novel epinephrine auto-injector, in the U.S. ...entis U.S. shall be responsible for manufacturing ...ible for the on-going development and for obtainin...n co-promotion rights in the territory. ,, Sano...
Breaking Medicine Technology:Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 2Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 3Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 3New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development 4612 1New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development 4612 2New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development 4612 3Humans related to orangutans not chimps says new Pitt Buffalo Museum of Science study 8892 1Humans related to orangutans not chimps says new Pitt Buffalo Museum of Science study 8892 2Humans related to orangutans not chimps says new Pitt Buffalo Museum of Science study 8892 3Humans related to orangutans not chimps says new Pitt Buffalo Museum of Science study 8892 4When palm trees gave way to spruce trees 8890 1When palm trees gave way to spruce trees 8890 2[0] Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th[0] Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013[0] Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector
...(Nasdaq: NVAX ) today announced financial results..., 2007. Novavax reported a net loss of $9.2 millio... 2007 compared to a net,loss of $6.1 million ($0.1...or the year ended December 31, 2007, the Company r...r share) compared to a net loss of $23.1,million (...
...harmaceuticals,Inc. today announced that enrollmen...ients that evaluates the safety and efficacy of it...rheumatoid arthritis (RA). MM-093 is a,recombinant...andomized, double-blind, placebo-controlled, Phase...ut the United States. The objective,of this study ...
Other Medicine Technology:Novavax Reports Fourth Quarter and 2007 Year-End Financial Results 2Novavax Reports Fourth Quarter and 2007 Year-End Financial Results 3Novavax Reports Fourth Quarter and 2007 Year-End Financial Results 4Novavax Reports Fourth Quarter and 2007 Year-End Financial Results 5Novavax Reports Fourth Quarter and 2007 Year-End Financial Results 6Novavax Reports Fourth Quarter and 2007 Year-End Financial Results 7Novavax Reports Fourth Quarter and 2007 Year-End Financial Results 8Novavax Reports Fourth Quarter and 2007 Year-End Financial Results 9Novavax Reports Fourth Quarter and 2007 Year-End Financial Results 10Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis 2(Date:11/30/2009)...AUSEN, Switzerland, Nov. 30 /PRNewswire-FirstCall/...nnounced that its 2010 annual general meeting of s...010 at 3:00 p.m. Central European time at the Park...rich, Switzerland. Registered shareholders as of J... to vote at the annual general meeting. Additiona...
(Date:11/30/2009)...LLE, Fla., Nov. 30 The launch of I...ailability of the first FDA-cleared, fully-automat...ysis by a radiologist of suspicious breast lesions...the Radiological Society of North America 2009 Ann...ship with leading experts in breast MRI, ONCAD for...
(Date:11/30/2009)...vember 30, 2009 ― Providing free medications...atients, lives at a relatively low cost for provin...archers at St. Michael,s Hospital in Toronto. , ...prescribed medications because they simply don,t f...he study,s lead author and a physician at St. Mich...
(Date:11/30/2009)...ills improve with specially designed program, stud...ews) -- A special, intensive early intervention pr...ng IQ along with children,s language and social sk...ashion, many children are able to learn and make r...uthor of the study, published online Nov. 30 in ...
(Date:11/30/2009)...LLS, N.J., Nov. 30 Kemin Foods, L....nc. and OmniActive Health Technologies, Ltd. ("Omn...heir dispute. The parties agree that Kemin,s US Pa...cess for Isolation, Purification and Recrystalliza...and Uses Thereof" and the reissues of that patent ...
Breaking Medicine News(10 mins):Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:Coverage of inexpensive drugs may increase length and quality of life after heart attack 2Health News:Working Intensely Early on May Help Autistic Kids 2Health News:Working Intensely Early on May Help Autistic Kids 3Health News:Working Intensely Early on May Help Autistic Kids 4[1] Tyco International Sets Date for 2010 Annual General Meeting of Shareholders[0] New Breast MRI Technology Enables Enhanced Breast Cancer Detection[0] Coverage of inexpensive drugs may increase length and quality of life after heart attack[0] Working Intensely Early on May Help Autistic Kids[0] OmniActive and Kemin Reach Amicable Settlement in Patent Dispute
...ment in balancing seizure control ... March 28 On the heels of the nation,s,largest ev...nal Walk for,Epilepsy, advocates today announced t...physician communication,around medication-related ...
... Parenthood affiliates in Florida,have been falsif...s show,that what happened in California is not an ...an Life League,renewed its call for a national inv...largest abortion chain is receiving,public funds a...
...heels of the nations largest event dedicated to th...sy, advocates today announced their recommendation...key challenges facing the epilepsy community. Chal...the survey, sponsored by ORTHO-McNEIL NEUROLOGICS,...
...ex:,ULU) today announced that it has scheduled a c...inancial results and provide a general business up...rn time., To participate in the conference call, ...nference. If you are unable to,listen to the live ...
...g Medical,Solutions, Inc. (Rising) and myMatrixx, ...d integration between Rising,s Workers, Compensati...rmacy benefits management,program. The partnership...ttp://www.newscom.com/cgi-bin/prnh/20080206/AQW030...
...Patient Satisfaction and Other ...tal Quality Alliance today,released the first Hosp...nd,Systems (HCAHPS) scores for hospitals nationwid...onal average in both,overall patient satisfaction ...
Other Medicine News:Health News:Leading Epilepsy Advocates Propose Strategies to Heighten Treatment Expectations and Close Patient and Physician Communication Gaps 2Health News:Leading Epilepsy Advocates Propose Strategies to Heighten Treatment Expectations and Close Patient and Physician Communication Gaps 3Health News:Leading Epilepsy Advocates Propose Strategies to Heighten Treatment Expectations and Close Patient and Physician Communication Gaps 4Health News:Leading Epilepsy Advocates Propose Strategies to Heighten Treatment Expectations and Close Patient and Physician Communication Gaps 5Health News:American Life League: Planned Parenthood Scandals 'Widespread' 2Health News:Epilepsy advocates propose strategies to heighten treatment expectations 2Health News:Epilepsy advocates propose strategies to heighten treatment expectations 3Health News:Epilepsy advocates propose strategies to heighten treatment expectations 4Health News:ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business Update 2Health News:Rising Medical Solutions Partners With myMatrixx to Deliver Integrated Pharmacy Management Solutions 2Health News:Hospital for Special Surgery Reports Scores on HCAHPS Survey 2Health News:Hospital for Special Surgery Reports Scores on HCAHPS Survey 3Leading Epilepsy Advocates Propose Strategies to Heighten Treatment Expectations and Close Patient and Physician Communication GapsAmerican Life League: Planned Parenthood Scandals 'Widespread'Epilepsy advocates propose strategies to heighten treatment expectationsULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business UpdateRising Medical Solutions Partners With myMatrixx to Deliver Integrated Pharmacy Management SolutionsHospital for Special Surgery Reports Scores on HCAHPS Survey
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |